AI for Cancer Care
AI built to expand cancer expertise, speed decisions, and improve care
Software · Cloud SaaSCompany source
Company profile
About Color Genomics
Color Health is a precision medicine company that has built the first and only ASCO-certified Virtual Cancer Clinic, delivering comprehensive oncologist-led cancer care across the entire cancer journey. The company provides direct clinical care from prevention and early detection through diagnosis, treatment planning, active treatment management, and survivorship care. Color's platform combines board-certified oncologists, AI-powered clinical tools, and at-home testing capabilities to expand access to cancer expertise at scale. The company serves employers, health plans, consultants, unions, and public sector organizations across all 50 states. Color's licensed medical group provides 24/7 access to cancer-specialized physicians who screen, diagnose, prescribe, order tests, manage symptoms, and ensure guideline-based follow-up. The platform integrates with existing healthcare infrastructure and in-network providers while maintaining clinical oversight throughout the patient journey. Color offers at-home screening kits for cervical, prostate, colorectal, and skin cancer, along with physician-directed referrals for breast and lung screening. The company's approach focuses on three key levers: nationwide access to care, speed of diagnosis and treatment, and direct clinical management by oncologists rather than simple navigation. Color Medical provides the clinical care while Color Health provides the platform and support services.
Company description Color Genomics official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Work at Color Genomics?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- all cancer types across the full cancer journey
- breast cancer
- cervical cancer
- colorectal cancer
- lung cancer
- prostate cancer
- skin cancer
Who it serves
- Consultants
- Employers
- Health Plans
- Public Sector Organizations
- Unions
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Geographic context
MarketsUnited States (all 50 states)
Company sourceOfficial website
Company milestones
Platform expansion
First and only Virtual Cancer Clinic to achieve ASCO certification, demonstrating meeting rigorous quality and safety standards as top cancer centers
Partnerships
Recorded partners
- American Society of Clinical Oncology (ASCO)
- in-network healthcare providers
- local cancer treatment facilities
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
AI for Cancer Care (Cancer Copilot)
AI-powered clinical decision support achieving 95%+ concordance with expert oncologists
Software · Cloud SaaSCompany source
At-Home Cancer Screening
At-home screening kits for cervical, prostate, colorectal, and skin cancer
Service · HybridCompany source
At-Home Cancer Screening Kits
At-home screening for cervical, prostate, colorectal, and skin cancer
Device · HybridCompany source
Cancer Copilot
AI-powered clinical decision support achieving 95%+ concordance with expert care
Software · Cloud SaaSCompany source
Color Assistant
Generative AI agent for breast cancer screening eligibility and scheduling
Software · Cloud SaaSCompany source
Color Swab Based HPV Test
Self-collection HPV test for cervical cancer screening
Device · HybridCompany source
Survivorship Care Management
Longitudinal oncologist-led care to reduce recurrence and support return to work
Service · Cloud SaaSCompany source
Virtual Cancer Clinic
ASCO-certified oncologist-led cancer care from screening through survivorship
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.Gastroenterology · May 1, 2024
Genetic counselor roles in the undiagnosed diseases network research study: Clinical care, collaboration, and curation.Journal of genetic counseling · Apr 1, 2022
Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).Genetics in medicine : official journal of the American College of Medical Genetics · Mar 1, 2022
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.Nature microbiology · Feb 1, 2022
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.Cancer prevention research (Philadelphia, Pa.) · Nov 1, 2021
Intronic Breakpoint Signatures Enhance Detection and Characterization of Clinically Relevant Germline Structural Variants.The Journal of molecular diagnostics : JMD · May 1, 2021
Clinical validation
Clinical-trial records
GENetic Education Risk Assessment and TEsting StudyNCT03762590 · Mentioned · ACTIVE NOT RECRUITING
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate CancerNCT04763980 · Mentioned · RECRUITING
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)NCT02620852 · Sponsor · RECRUITING
Genetic Testing for Men With Metastatic Prostate CancerNCT03503097 · Mentioned · TERMINATED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
66% faster diagnosis
time to confirmed diagnosis
77% increase in screening adherence
guidelines-based screenings
>75% of costly care gaps closed
clinical care management
$23,000 saved per patient
overall patient cost savings
$6,000 saved per survivor
survivorship care management
2.8:1 ROI in Year 1
return on investment for organizations
37% lower imaging costs vs national averages
diagnostic imaging utilization
$63,000+ in avoidable spend for every earlier-stage detection
early detection impact
$13,000 saved per cancer patient on clinical services
clinical service costs
$20,000 saved from each avoided hospitalization
preventing avoidable ED visits
$175,000 saved per prevented recurrence
survivorship care and monitoring
36% reduction in depression and anxiety symptoms
integrated behavioral health support
All of Us Research Program
Lead partner in national initiative to return health-related genetic information to over one million people, serving as one of three Clinical Validation Laboratories and sole provider of genetic counseling
Delivering meaningful genetic insights to a more diverse population of 1M+ participants
Carrum Health Partnership
Connected proactive clinical care with Centers of Excellence for cancer treatment, reducing fragmentation and speeding access to care from prevention through survivorship
Improved outcomes and simplified cancer benefit experience through integrated care model
Collective Health Partnership
Shifted cancer care from reactive to proactive through seamless integration of Virtual Cancer Clinic with My Collective portal, enabling eligibility tracking and outcomes reporting
Faster diagnosis, fewer ER visits, and better support powered by data integration
Employers (aggregate)
Virtual cancer clinic providing oncologist-led care across the cancer journey
66% faster diagnosis, 77% increase in screening adherence, >75% of costly care gaps closed, $23,000 saved per patient, $6,000 saved per survivor, 2.8:1 ROI in Year 1
Google Cloud Partnership
Expanded access to breast cancer screening using AI to augment clinical care, determine eligibility for mammograms, and schedule screenings while decreasing physician burden
Expedited access to essential healthcare services through AI-powered Color Assistant
Health Plans (aggregate)
Comprehensive cancer care management from screening through survivorship
37% lower imaging costs vs national averages, $63,000+ in avoidable spend for every earlier-stage detection, $13,000 saved per cancer patient on clinical services, 77% increase in guidelines-based screenings, $20,000 saved from each avoided hospitalization, $175,000 saved per prevented recurrence, 36% reduction in depression & anxiety symptoms, 2.8:1 ROI in Year 1
Maven Clinic Partnership
Integrated oncofertility services to support family building after cancer diagnosis, ensuring patients receive early referrals and evidence-based fertility preservation counseling
First-of-their-kind oncofertility services enabling informed reproductive decisions for cancer patients
Memorial Sloan Kettering (MSK Direct) Partnership
Combined MSK's world-class cancer care with Color's nationwide Virtual Cancer Clinic to provide timely diagnosis, treatment, and support regardless of employee location
Expanded access to expert cancer care for employees nationwide
UCSF Partnership
Tested AI-powered Cancer Copilot to help clinicians deliver guideline-based cancer care
Achieved over 95% concordance on real-world patient cases
WISDOM Trial Partnership
Exclusive genomic testing partner for 100,000-person study comparing annual mammograms to personalized, risk-based screening in partnership with University of California system and Sanford Health
Expanding access to smarter breast cancer prevention for 100,000 participants
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Color Genomics
Recent articles published on Color Genomics's official website.
AIUsing AI to help healthcare providers in the cancer spaceRead more
Read on Color GenomicsAILLMs in healthcare: tackling implementation challenges methodicallyRead more
Read on Color GenomicsCancer CareColor becomes the first virtual clinic to earn ASCO Certified Designation for quality in cancer careRead more
Read on Color GenomicsAIBringing cancer expertise to a doctor near you: Colorâs copilot and partnership with OpenAIRead more
Read on Color GenomicsAIUsing AI to accelerate cancer diagnosis to treatment time for your workforceRead more
Read on Color Genomics07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.